Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vulnerable Populations | 1 | 2022 | 163 | 0.720 |
Why?
|
| IgA Deficiency | 1 | 2021 | 6 | 0.710 |
Why?
|
| Radiodermatitis | 1 | 2020 | 10 | 0.680 |
Why?
|
| Food Contamination | 1 | 2020 | 48 | 0.670 |
Why?
|
| Churg-Strauss Syndrome | 1 | 2020 | 26 | 0.670 |
Why?
|
| Insect Proteins | 1 | 2020 | 40 | 0.660 |
Why?
|
| Granulomatosis with Polyangiitis | 1 | 2020 | 44 | 0.660 |
Why?
|
| Coccidioidomycosis | 1 | 2019 | 7 | 0.640 |
Why?
|
| Lung Diseases, Fungal | 1 | 2019 | 13 | 0.630 |
Why?
|
| Prednisone | 1 | 2020 | 243 | 0.620 |
Why?
|
| Anaphylaxis | 1 | 2020 | 105 | 0.600 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2019 | 189 | 0.550 |
Why?
|
| Glucocorticoids | 1 | 2020 | 596 | 0.480 |
Why?
|
| Pneumonia | 1 | 2019 | 640 | 0.420 |
Why?
|
| Microbiota | 1 | 2021 | 761 | 0.390 |
Why?
|
| Neoplasms | 2 | 2023 | 2661 | 0.300 |
Why?
|
| Disease Susceptibility | 2 | 2019 | 345 | 0.270 |
Why?
|
| Asthma | 1 | 2019 | 2293 | 0.250 |
Why?
|
| B-Lymphocytes, Regulatory | 1 | 2023 | 3 | 0.210 |
Why?
|
| Avena | 1 | 2020 | 4 | 0.170 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 1 | 2020 | 36 | 0.170 |
Why?
|
| Hypersensitivity | 1 | 2023 | 257 | 0.170 |
Why?
|
| Oryza | 1 | 2020 | 33 | 0.170 |
Why?
|
| Skin Tests | 1 | 2020 | 101 | 0.170 |
Why?
|
| Insecta | 1 | 2020 | 65 | 0.170 |
Why?
|
| Immunoblotting | 1 | 2020 | 307 | 0.160 |
Why?
|
| Coccidioides | 1 | 2019 | 5 | 0.160 |
Why?
|
| Immunoglobulin A | 1 | 2021 | 210 | 0.160 |
Why?
|
| Chest Tubes | 1 | 2019 | 29 | 0.160 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2019 | 43 | 0.150 |
Why?
|
| Dysbiosis | 1 | 2021 | 181 | 0.150 |
Why?
|
| Chest Pain | 1 | 2019 | 92 | 0.150 |
Why?
|
| Antifungal Agents | 1 | 2019 | 136 | 0.150 |
Why?
|
| Immunoglobulin E | 1 | 2020 | 342 | 0.150 |
Why?
|
| Forkhead Transcription Factors | 1 | 2019 | 190 | 0.150 |
Why?
|
| Humans | 9 | 2024 | 137294 | 0.130 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2019 | 387 | 0.130 |
Why?
|
| Combined Modality Therapy | 1 | 2019 | 1237 | 0.130 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 1484 | 0.110 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2020 | 805 | 0.110 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2019 | 1095 | 0.100 |
Why?
|
| DNA-Binding Proteins | 1 | 2019 | 1501 | 0.090 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 2836 | 0.090 |
Why?
|
| Cell Differentiation | 1 | 2019 | 1987 | 0.090 |
Why?
|
| Transcription Factors | 1 | 2019 | 1720 | 0.090 |
Why?
|
| Aged | 2 | 2020 | 23851 | 0.080 |
Why?
|
| Surveys and Questionnaires | 1 | 2022 | 5769 | 0.080 |
Why?
|
| Female | 3 | 2020 | 73052 | 0.070 |
Why?
|
| Adult | 2 | 2020 | 37724 | 0.070 |
Why?
|
| Risk Factors | 1 | 2019 | 10368 | 0.060 |
Why?
|
| Male | 2 | 2019 | 67560 | 0.050 |
Why?
|
| Immune System | 1 | 2023 | 177 | 0.050 |
Why?
|
| Animals | 2 | 2020 | 36862 | 0.040 |
Why?
|
| Child | 1 | 2020 | 21999 | 0.040 |
Why?
|
| Critical Care | 1 | 2024 | 584 | 0.040 |
Why?
|
| Middle Aged | 1 | 2019 | 33310 | 0.040 |
Why?
|
| Vaccination | 1 | 2024 | 1379 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2019 | 1150 | 0.030 |
Why?
|
| Hospitalization | 1 | 2024 | 2214 | 0.030 |
Why?
|
| Autoimmunity | 1 | 2019 | 908 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2019 | 916 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 5753 | 0.020 |
Why?
|
| Mice | 1 | 2019 | 17774 | 0.010 |
Why?
|